Bulletin of the World Health Organization · 2022 · 50 citations · 9 references
Public AffairsHealth PolicyInfectious DiseasesHealth EquityImmunizationVaccinologyImmunization PolicyVaccinationVaccination PolicyVaccine PolicyEquity In Vaccination CoverageGlobal Vaccine AccessIncident AnalysisVaccination EconomicsVaccination FinancingVaccine Access EquityVaccine Distribution EquityVaccines Access
Objective: To evaluate equity in the allocation and distribution of vaccines for coronavirus disease 2019 (COVID-19) to countries and territories participating in the COVID-19 Vaccines Global Access (COVAX) Facility. Methods: We used publicly available data on the numbers of COVAX vaccine doses allocated and distributed to 88 countries and territories qualifying for COVAX-sponsored vaccine doses and 60 countries self-financing their vaccine doses facilitated by COVAX. We conducted a benefit-incident analysis to examine the allocation and distribution of vaccines based on countries' gross domestic product (GDP) per capita. We plotted cumulative country-level per capita allocation and distribution of COVID-19 vaccines from COVAX against the ranked per capita GDP of the countries and territories to generate a measure of the equity of COVAX benefits. Findings: By 23 January 2022 the COVAX Facility had allocated a total of 1 678 517 990 COVID-19 vaccine doses, of which 1 028 291 430 (61%) doses were distributed to 148 countries and territories. Taking account of COVAX subsidies, we found that countries and territories with low per capita GDP benefited more than higher-income countries in the numbers of vaccines. The benefits increased further when the analysis was adjusted by population age group (aged 65 years and older). Conclusion: The COVAX Facility is helping to balance global inequities in the allocation and distribution of COVID-19 vaccines. However, COVAX alone has not been enough to reverse the inequality of total COVID-19 vaccine distribution. Future studies could examine the equity of all COVID-19 vaccine allocation and distribution beyond the COVAX-facilitated vaccines.
9
A global database of COVID-19 vaccinations
Edouard Mathieu, Hannah Ritchie, Esteban Ortiz-Ospina et al. · Nature Human Behaviour · 2021 · 2.1K citations · Full text
COVID-19 and the cost of vaccine nationalism
Marco Hafner, Erez Yerushalmi, Clement Fays et al. · RAND Corporation eBooks · 2020 · 93 citations · Full text